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OBJECTIVE — To explore the association between epistasis among related genes of the
renin-angiotensin system (RAS) and type 2 diabetes.
RESEARCH DESIGN AND METHODS — Gene polymorphisms were genotyped in
394type2diabeticpatientsand418healthycontrolsubjectsinthiscase-controlstudy.Weused
the multifactor dimensionality reduction method to identify gene-gene interactions.
RESULTS — Nosinglelocuswasassociatedwithtype2diabetes,exceptfortheinsert/deletion
(I/D)polymorphismoftheACEgeneinfemalesubjects.Inmulti-locusanalyses,inmalesubjects
the model of rs2106809 (ACE2), rs220721 (Mas), rs699 (AGT), and I/D (ACE) was signiﬁcant
(P  0.043). This combination was associated with a 4.00 times (95% CI 2.51–6.38; P 
0.0001) greater prevalence of type 2 diabetes. In female subjects, the model of rs2106809
(ACE2), I/D (ACE), and rs1403543 (AGTR2) was signiﬁcant (P  0.012). This three-locus
combination was associated with a 2.76 times (1.91–3.97; P  0.0001) greater prevalence of
type 2 diabetes.
CONCLUSIONS — Interactions among RAS-related genes were associated with type 2 dia-
betes in a Chinese population.
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O
ver the past few years, a number of
new genetic loci associated with
type 2 diabetes have been uncov-
ered based on genome-wide association
scans.Investigationsintogene-geneinter-
actions,however,areuncommonbecause
the method is computationally challeng-
ing (1). In type 2 diabetes, attempts to
elucidatepossibleepistasishaveprovided
only a few examples (2–4).
Recently, studies have supported the
idea that using our understanding of bi-
ology, including that of cytokine net-
works and hormone systems, may help
guide analysis of epistasis (5,6). Clinical
evidence suggests that the renin-
angiotensin system (RAS) is associated
with the etiology of type 2 diabetes (7–9).
However,theinﬂuenceofgeneticinterac-
tion within the RAS on type 2 diabetes
susceptibilityisstillunknown.Theaimof
our study was to explore the contribution
of epistasis among RAS-related genes.
RESEARCH DESIGN AND
METHODS— The study subjects
were selected from an ongoing large-scale
population-based cohort (10). Partici-
pants without previously known diabetes
were selected from the 2,826 registered
individuals. Written informed consent
was obtained from each participant. Sub-
jects’ fasting plasma glucose (FPG) was
obtained from our previous study, and
the subjects with FPG 5.6 mmol/l per-
formed a 75-g oral glucose tolerance test.
Diabetes was diagnosed according to the
1999 World Health Organization crite-
ria. All subjects in both groups were
matched for blood pressure, serum cre-
atinine, and age.
Eight single nucleotide polymor-
phisms (SNPs) from seven RAS-related
genes were then assessed; these were as
follows: rs699 (AGT), insert/deletion
(I/D) polymorphism (ACE), rs2106809
and rs2074192 (ACE2), rs5186 (AGTR1),
rs1403543 (AGTR2), rs220721 (Mas),
and rs1799722 (BDKRB2). Detection was
completed using a MassARRAY platform
(Sequenom, San Diego, CA).
Weusedthemultifactordimensionality
reduction (MDR) software 2.0- (http://
www.multifactordimensionalityreduction.
org) to identify gene-gene interactions.
RESULTS— A total of 394 unrelated
type 2 diabetic patients and 418 healthy
control subjects were enrolled in this
case-control study. Demographic and
clinical characteristics of the subjects are
given in supplementary Table A1 in the
online appendix available at http://care.
diabetesjournals.org/cgi/content/full/dc10-
0349/DC1.Age,bloodpressure,andserum
creatinine were comparable between the
two groups. Because of the ACE2 and
AGTR2 genetic presence in the X chromo-
some, the analysis was performed sepa-
rately for male and female subjects.
Association analyses of male
subjects
No single-locus analysis showed a signif-
icant association with type 2 diabetes
(supplementary Table A2). According to
theMDRanalysisthroughﬁve-locuscom-
parisons, a signiﬁcant interaction was ob-
served for variant alleles in the following
three loci: rs2106809 (ACE2), rs220721
(Mas), and I/D (ACE) (Table 1). This
combination had the maximum cross-
validation consistency of 10 that was sig-
niﬁcant at the 0.01 level of P value, as
calculated using the sign test. The four-
locus model of rs2106809 (ACE2),
rs220721 (Mas), rs699 (AGT), and I/D
(ACE) scored nine of cross-validation
consistency that was signiﬁcant at the
0.05 level of P value. The four-locus
model was also signiﬁcant in the 1,000
permutation test (Table 1). In the 
2 test,
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tion of four loci increased the risk of type
2 diabetes by 4.00 times (95% CI 2.51–
6.38, P  0.0001).
Association analyses of female
subjects
The results of the single-locus analyses
showed that only I/D from ACE was asso-
ciated with type 2 diabetes (P  0.039)
(supplementary Table A2). According to
the MDR analysis, the most signiﬁcant
combination was the three-locus model,
rs2106809 (ACE2), I/D (ACE), rs1403543
(AGT2R), which had the maximum cross-
validation consistency of 10 and was signif-
icant at the 0.012 level of P value, as
calculated using permutation test. In the 
2
test, the OR of high-risk combination of
three loci increased the risk of type 2 diabe-
tes by 2.76 times (95% CI 1.91–3.97, P 
0.0001).
The logistic regression model sug-
gestedanonsigniﬁcantgene-geneinterac-
tion in a multiplicative manner in the
male and female participants.
CONCLUSIONS — The results from
our study evidenced that although main
effects of the individual loci may not be
observed, the interaction among RAS-
related genes is directly correlated with
the susceptibility of type 2 diabetes. It is
thus possible that loci contribute to some
complexdiseasesonlybytheirinteraction
with other genes, although the main ef-
fects of the individual loci may be too
small to be observed (11).
Identifying genes in multi-factorial
diseasesisdifﬁcult.Thereisnoconsensus
as to the best strategy for detecting epi-
static interactions in humans (12). In the
present study, with MDR analysis we
found interactions among RAS-related
genes. These interactions make mecha-
nistic sense because these genes are in-
volved in the same biological pathways
(13). However, the susceptibility interac-
tion was not conﬁrmed by the logistic
regression analysis. A possible reason
for these inconsistent results is that
MDR did not detect the interaction de-
ﬁned by “deviation from the multiplica-
tive” as in the logistic regression model.
Only the signiﬁcant results from MDR
showed that the combination of differ-
ent loci may increase or decrease the
risk of disease (14). Based on the asso-
ciation OR of 1.3 (typical for type 2 di-
abetes)andallelefrequencyof0.49,this
study showed over 65% power to detect
interactions of genes.
A limitation of our study is that by
representingeachgenelocuswithasingle
SNP, multiple association signals for a
givengenemightbemissed(15).Further-
more, our ﬁndings need to be replicated
in further studies with larger samples and
different populations.
In conclusion, we were the ﬁrst to
show that the interactions among RAS-
related genes are associated with type 2
diabetes.
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